Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for xenografting

A Dorling1, R I Lechler

  • 1Department of Immunology, Royal Postgraduate Medical School, University of London, Hammersmith Hospital, UK.

Current Opinion in Immunology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplant outcomes after de novo donor specific antibody (DSA) development correlate with persistence of DSA.

Transplant immunology·2025
Same author

Real-time organ perfusion monitoring of human kidney transplants using <i>ex vivo</i> normothermic perfusion and reflectance spectroscopy.

Royal Society open science·2025
Same author

Highly sensitised individuals present a distinct Treg signature compared to unsensitised individuals on haemodialysis.

Frontiers in transplantation·2024
Same author

Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial.

BMC nephrology·2023
Same author

Author Correction: Diversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft model.

Scientific reports·2020
Same author

Regulatory T cells: tolerance induction in solid organ transplantation.

Clinical and experimental immunology·2017
Same journal

Noncanonical ion channel signaling in neurovascular barrier regulation and immune cell trafficking.

Current opinion in immunology·2026
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
See all related articles

Understanding hyperacute rejection and endothelial cell activation is key to successful xenotransplantation. New strategies, including transgenic organs, promise improved survival for pig organs in humans.

Area of Science:

  • Transplantation immunology
  • Xenotransplantation research
  • Endothelial cell biology

Background:

  • Hyperacute rejection (HAR) and endothelial cell activation are critical barriers in discordant xenotransplantation.
  • Understanding these processes is essential for advancing xenotransplantation.
  • Current knowledge gaps hinder the clinical application of xenografts.

Purpose of the Study:

  • To elucidate the mechanisms of hyperacute rejection and endothelial cell activation in xenograft rejection.
  • To identify novel targets and strategies for preventing xenograft rejection.
  • To assess the potential of new therapeutic agents and transgenic organs for improving xenotransplant outcomes.

Main Methods:

  • Identification of endothelial cell antigens targeted by human antibodies.

Related Experiment Videos

  • Investigation of mechanisms underlying endothelial cell activation.
  • Evaluation of novel preventative strategies for hyperacute rejection.

    • Main Results:

    • New insights into xenograft rejection mechanisms, including endothelial cell activation and accommodation.
    • Identification of specific endothelial cell antigens targeted by human anti-pig antibodies.
    • Development of promising strategies, such as therapeutic agents and transgenic organs, to prevent hyperacute rejection.

    Conclusions:

    • Advances in understanding xenograft rejection mechanisms are paving the way for clinical xenotransplantation.
    • Novel approaches show significant promise for improving the early survival of transplanted pig organs.
    • Clinical xenotransplantation is becoming an achievable reality.